Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave

Abstract

The high incidence of possible and probable CAPA in critically ill COVID-19 patients is alarming. The increase in 30-day mortality in CAPA highlights the need for active surveillance and management strategies in critically ill COVID-19 patients.